经蝶入路显微手术切除儿童垂体腺瘤
该回顾性队列分析纳入2002年2月至2017年5月接受经蝶入路垂体腺瘤切除术的19岁以下患者,共识别24例儿童病例。泌乳素瘤(29.2%)和促肾上腺皮质激素分泌型腺瘤(20.8%)最常见,全切率75.0%,激素功能完全正常化率91.7%,随访24.7±32.1个月无肿瘤复发。作者认为现代经蝶显微手术是儿童垂体腺瘤安全、耐受良好且有效的方式。
要点
- 儿童垂体腺瘤经蝶显微手术全切率为75.0%,激素功能完全正常化率为91.7%。
- 术后33.3%患者需激素替代治疗,50.0%使用脂肪/筋膜修补,4.2%行腰椎穿刺处理脑脊液漏。
- 随访24.7±32.1个月期间无肿瘤复发。
核心结论
- 现代经蝶显微手术是儿童垂体腺瘤安全、耐受良好且有效的治疗方式。
研究设计与样本
- 回顾性队列分析,纳入2002年2月至2017年5月接受经蝶入路垂体腺瘤切除术的19岁以下患者。
- 在总共634例接受经蝶入路垂体腺瘤切除术的患者中,识别出24例儿童病例。
主要发现
- 泌乳素瘤占29.2%,促肾上腺皮质激素分泌型腺瘤占20.8%,为最常见的组织学类型。
- 全切率为75.0%,激素功能完全正常化率为91.7%。
- 8例患者(33.3%)需要术后激素替代治疗。
- 12例患者(50.0%)使用了脂肪/筋膜,1例患者(4.2%)围手术期行腰椎穿刺处理脑脊液漏。
- 随访24.7±32.1个月期间无肿瘤复发。
临床怎么用
- 原文结论认为现代经蝶显微手术是儿童垂体腺瘤安全、耐受良好且有效的治疗方式。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Pituitary adenomas are uncommon in the pediatric population. Although medical treatment can be effective in treating prolactinomas and some growth hormone-secreting tumors, resection is indicated in the setting of pituitary apoplexy, large or giant pituitary adenomas causing mass effect or visual loss, or when medical therapy becomes ineffective or intolerable. Modern microsurgical transsphenoidal approaches are potential avenues for resection in pediatric patients. We evaluated the outcomes and safety of this approach. METHODS: A retrospective cohort analysis was performed from February 2002 through May 2017 for patients younger than 19 years of age that underwent a transsphenoidal approach for pituitary adenoma resection. RESULTS: Among a total of 634 patients who underwent transsphenoidal approach for pituitary adenoma resection, 24 pediatric cases were identified. Prolactinomas (29.2%) and adrenocorticotropic hormone-secreting (20.8%) pituitary adenomas were the most commonly encountered histologies. Gross total resection was achieved in 75.0% of patients, and complete hormone function normalization was seen in 91.7% of patients. Eight patients (33.3%) required postoperative hormone replacement therapy. Twelve patients (50.0%) underwent fat/fascia use and 1 patient (4.2%) underwent lumbar puncture perioperatively for management of cerebrospinal fluid leak. There were no tumor recurrences during a follow-up period of 24.7 ± 32.1 months. CONCLUSIONS: A modern transsphenoidal microsurgical approach proved to be a safe, well-tolerated, and effective modality in the setting of pediatric pituitary adenomas.
引用
- Abunimer AM, Abou-Al-Shaar H, Azab MA, et al. Transsphenoidal Approaches for Microsurgical Resection of Pituitary Adenomas in Pediatric Patients. World Neurosurg. 2018. PMID: 30476659. doi:10.1016/j.wneu.2018.11.117
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。